Potential Blood and Tissue Protein Biomarkers of Canine Mammary Gland Tumours – A Review*
References
- Alani I.S., Al-Biaty H.S. (2024). Epithelial periostin expression in canine mammary tumors. Adv. Anim. Vet. Sci., 12: 1705–1715.
- Ariyarathna H., Thomson N.A., Aberdein D., Perrott M.R., Munday J.S. (2020 a). Increased programmed death ligand (PDL1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression is associated with metastasis and poor prognosis in malignant canine mammary gland tumours. Vet. Immunol. Immunopathol., 230: 110142.
- Ariyarathna H., Thomson N., Aberdein D., Munday J.S. (2020 b). Chemokine gene expression influences metastasis and survival time of female dogs with mammary carcinoma. Vet. Immunol. Immunopathol., 227: 110075.
- Birdi R., Kumar B.V.S., Gupta K., Kashyap N., Kumar A. (2019). Circulating level of heat shock protein 27 is elevated in dogs with mammary tumors. 3 Biotech, 9: 229.
- Borecka P., Ciaputa R., Janus I., Bubak J., Piotrowska A., Ratajczak-Wielgomas K., Podhorska-Okolów M., Dzięgiel P., Nowak M. (2020 a). Expression of periostin in mammary cancer cells of female dogs. In vivo, 34: 3255–3262.
- Borecka P., Ratajczak-Wielgomas K., Ciaputa R., Kandefer-Gola M., Janus I., Piotrowska A., Kmiecik A., Podhorska-Okolów M., Dzięgiel P., Nowak M. (2020 b). Expression of periostin in cancer-associated fibroblasts in mammary cancer in female dogs. In vivo, 34: 1017–1026.
- Briscoe J., Thérond P.P. (2013). The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol., 14: 416–429.
- Bujak J.K., Szopa I.M., Pingwara R., Kruczyk O., Krzemińska N., Mucha J., Majchrzak-Kuligowska K. (2020). The expression of selected factors related to T lymphocyte activity in canine mammary tumors. Int. J. Mol. Sci., 21: 2292.
- Burrai G.P., Tanca A., Cubeddu T., Abbondio M., Polinas M., Addis M.F., Antuofermo E. (2017). A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neo-plastic mammary lesions. BMC Vet. Res., 13: 38.
- Burrai G.P., Gabrieli A., Moccia V., Zappulli V., Porcellato I., Brachelente C., Pirino S., Polinas M., Antuofermo E. (2020). A statistical analysis of risk factors and biological behavior in canine mammary tumors: a multicenter study. Animals, 10: 1687.
- Cao J., Kouznetsova V.L., Tsigelny I.F. (2019). Molecular mechanisms of canine cancers. OBM Genetics, 3: 071.
- Chang S.C., Yuan S.H., Li C.Y., Chang H.M., Wang H.C., Pan Y.A., Hsueh P.C., Wu C.C., Yang Y., Liu H.P. (2021). Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours. Vet. Comp. Oncol., 19: 172–182.
- Chatterjee S., Burns T.F. (2017). Targeting heat shock proteins in cancer: a promising therapeutic approach. Int. J. Mol. Sci., 18: 1978.
- Chen H., Yue J.X., Yang S.H., Ding H., Zhao R.W., Zhang S. (2009). Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer. J. Exp. Clin. Cancer Res., 28: 43.
- Chen L., Flies D.B. (2013). Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol., 13: 227–242.
- Chen Y.C., Chen Y.Y., Liao J.W., Chang S.C. (2018). Expression and prognostic value of c-met in canine mammary tumours. Vet. Comp. Oncol., 16: 670–676.
- Cohen I., Rider P., Vornov E., Tomas M., Tudor C., Wegner M., Brondani L., Freudenberg M., Mittler G., Ferrando-May E., Dinarello C. A., Apte R.N., Schneider R. (2015). IL-1α is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity. Sci. Rep., 5: 14756.
- Compton C. (2020). Cancer: The Enemy from Within. Springer: Cham, Switzerland, pp. 25–107.
- Cordeiro Y.G., Mulder L.M., van Zeijl R.J.M., Paskoski L.B., van Veelen P., de Ru A., Strefezzi R.F., Heijs B., Fukumasu H. (2021). Proteomic analysis identifies FNDC1, A1BG, and antigen processing proteins associated with tumor heterogeneity and malignancy in a canine model of breast cancer. Cancers, 13: 5901.
- Coveñas R., Muñoz M. (2014). Cancer progression and substance P. Histol. Histolpathol., 29: 881–890.
- Coy J.F., Dübel S., Kioschis P., Thomas K., Micklem G., Delius H., Poustka A. (1996). Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics, 32: 309–316.
- Davoodian M., Boroumand N., Mehrabi Bahar M., Jafarian A.H., Asadi M., Hashemy S.I. (2019). Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer. Mol. Biol. Rep., 46: 1285–1293.
- de Andrés P.J., Illera J.C., Cáceres S., Díez L., Pérez-Alenza M.D., Peña L. (2013). Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer. Bet. Immunol. Immunopathol., 152: 245–251.
- Duffy M.J., Murray A, Synnott N.C., O'Donovan N., Crown J. (2017). Vitamin D analogues: potential use in cancer treatment. Crit. Rev. Oncol. Hematol., 112: 190–197.
- Edmunds G., Beck S., Kale K.U., Spasic I., O'Neill D., Brodbelt D., Smalley M.J. (2023). Associations between dog breed and clinical features of mammary epithelial neoplasia in bitches: an epidemiological study of submissions to a single diagnostic pathology centre between 2008–2021. J. Mammary Gland Biol. Neoplasia, 28: 6.
- Ežerskytė A., Zamokas G., Grigonis A., Juodžiukynienė N. (2011). The retrospective analysis of mammary tumors in dogs. Vet. Med. Zoot., 53: 3–8.
- Feng L., Qi Q., Wang P., Chen H., Chen Z., Meng Z., Liu L. (2020). Serum level of CCL2 predicts outcome of patients with pancreatic cancer. Acta Gastroenterol. Belg., 83: 295–299.
- Ferreira T., Gama A., Seixas F., Faustino-Rocha A.I., Lopes C., Gaspar V.M., Mano J.F., Medeiros R., Oliveira P.A. (2023). Mammary glands of women, female dogs and female rats: similarities and differences to be considered in breast cancer research. Vet. Sci., 10: 379.
- Fhaikrue I., Srisawat W., Nambooppha B., Pringproa K., Thongtharb A., Prachasilchai W., Sthitmatee N. (2020). Identification of potential canine mammary tumour cell bio-markers using proteomic approach: Differences in protein profiles among tumour and normal mammary epithelial cells by two-dimensional electrophoresis-based mass spectrometry. Vet. Comp. Oncol., 18: 787–795.
- Fisher D.T., Appenheimer M.M., Evans S.S. (2014). The two faces of IL-6 in the tumor microenvironment. Semin. Immunol., 26: 38–47.
- Franco-Martínez L., Gelemanović A., Horvatić A., Contreras-Aguilar M.D., Dąbrowski R., Mrljak V., Cerón J.J., Martínez-Subiela S., Tvarijonaviciute A. (2020). Changes in serum and salivary proteins in canine mammary tumors. Animals, 10: 741.
- Freeman A., Hetzel U., Cripps P., Mobasheri A. (2010). Expression of the plasma membrane markers aquaporin 1 (AQP1), glucose transporter 1 (GLUT1) and Na, K-ATPase in canine mammary glands and mammary tumours. Vet. J., 185: 90–93.
- Fujimoto N., Taniguchi Y., Sonoda H., Kaneko Y., Matsuzaki T., Itoh T., Hirai T., Uchida K., Ikeda M. (2024). Expression patterns of aquaporins 1, 3, 5 in canine mammary gland carcinomas. J. Vet. Med. Sci., 86: 168–179.
- Fymat A.L. (2017). Genetics, epigenetics and cancer. Canc. Therapy Oncol. Int. J., 4: 555634.
- Gama A., Paredes J., Albergaria A., Gartner F., Schmitt F. (2004). P-cadherin expression in canine mammary tissues. J. Comp. Pathol., 130: 13–20.
- Griffin N., Dowling M. (2018). Vitamin D supplementation and clinical outcomes in cancer survivorship. Br. J. Nurs., 27: 1121–1128.
- Grizzi F., Di Ieva A., Russo C., Frezza E.E., Cobos E., Muzzio P.C., Chiriva-Internati M. (2006). Cancer initiation and progression: an unsimplifiable complexity. Theor. Biol. Med. Model., 3: 37.
- Hernández-Suárez B., Gillespie D.A., Pawlak A. (2022). DNA damage response proteins in canine cancer as potential research targets in comparative oncology. Vet. Comp. Oncol., 20: 347–361.
- Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L.F., Kudo A. (1999). Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res., 14: 1239–1249.
- Hu Q., Baeg G.H. (2017). Role of epigenome in tumorigenesis and drug resistance. Food Chem. Toxicol., 109: 663–668.
- Huang W.Q., Wang J.G., Chen L., Wei H.J., Chen H. (2010). SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D. J. Exp. Clin. Cancer Res., 29: 55.
- Hussain S., Saxena S., Shrivastava S., Arora R., Singh R.J., Jena S.C., Kumar N., Sharma A.K., Sahoo M., Tiwari A.K., Mishra B.P., Singh R.K. (2018). Multiplexed autoantibody signature for serological detection of canine mammary tumours. Sci. Rep., 8: 15785.
- Kaewsakhorn T., Kisseberth W.C., Capen C.C., Hayes K.A., Calverley M.J., Inpanbutr N. (2005). Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line. Anticancer Res., 25: 2689–2696.
- Kaszak I., Ruszczak A., Kanafa S., Kacprzak K., Król M., Jurka P. (2018). Current bio-markers of canine mammary tumors. Acta Vet. Scand., 60: 66.
- Kaszak I., Witkowska-Piłaszewicz O., Domrazek K., Jurka P. (2022). The novel diagnostic techniques and biomarkers of canine mammary tumors. Vet. Sci., 9: 526.
- Khan G.J., Sun L., Khan S., Yuan S., Nongyue H. (2018). Versatility of cancer associated fibroblasts: commendable targets for anti-tumor therapy. Curr. Drug Targets, 19: 1573–1588.
- Kim H.S., Cho J.Y. (2024). Exosome proteomes reveal glycolysis-related enzyme enrichment in primary canine mammary gland tumor compared to metastases. Proteome Sci., 22: 4.
- Klopfleisch R., Klose P., Weise C., Bondzio A., Multhaup G., Einspanier R., Gruber A.D. (2010). Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. J. Proteome Res., 9: 6380–6391.
- Klopfleisch R., von Euler H., Sarli G., Pinho S.S., Gärtner F., Gruber A.D. (2011). Molecular carcinogenesis of canine mammary tumors: news from an old disease. Vet. Pathol., 48: 98–116.
- Klose P., Weise C., Bondzio A., Multhaup G., Einspanier R., Gruber A.D., Klopfleisch R. (2011). Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?. J. Proteome Res., 10: 4405–4415.
- Koo H., Lee S., Kim W.H. (2023). Usability of serum hedgehog signalling proteins as bio-markers in canine mammary carcinomas. BMC Vet. Res., 19: 231.
- Kumaraguruparan R., Prathiba D., Nagini S. (2006). Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours. Res. Vet. Sci., 81: 218–224.
- Kunakornsawat S., Rosol T.J., Capen C.C., Reddy G.S., Binderup L., Inpanbutr N. (2002). Effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its analogues (EB1089 and analog V) on canine adenocarcinoma (CAC-8) in nude mice. Biol. Pharm. Bull., 25: 642–647.
- Lazennec G., Richmond A. (2010). Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med., 16: 133–144.
- Li D., Chan D.W. (2014). Proteomic cancer biomarkers from discovery to approval: it's worth the effort. Expert Rev. Proteomics, 11: 135–136.
- Li X., Deng W., Nail C.D., Bailey S.K., Kraus M.H., Ruppert J.M., Lobo-Ruppert S.M. (2006). Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene, 25: 609–621.
- Lincet H., Icard P. (2015). How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?. Oncogene, 34: 3751–3759.
- Liu P., Lu Y., Yang Y., Chen X., Xiong W., Sun J. (2022). Expression of tumour transcription factor GLI1 in canine mammary tumours tissue. Vet. Med. Sci., 8: 1451–1457.
- Lu L., Wu M., Zhao F., Fu W., Li W., Li X., Liu T. (2016). Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis. Oncotarget, 7: 69087–69096.
- Lubowicka E., Przylipiak A., Zajkowska M., Piskór B.M., Malinowski P., Fiedorowicz W., Ławicki S. (2018). Plasma chemokine CCL2 and its receptor CCR2 concentrations as diagnostic biomarkers for breast cancer patients. Biomed. Res. Int., 2124390.
- Machado V.S., Crivellenti L.Z., Bottari N.B., Tonin A.A., Pelinson L.P., Borin-Crivellenti S., Santana A.E., Torbitz V.D., Moresco R.N., Duarte T., Duarte M.M., Schetinger M.R., Morsch V.M., Jaques J.A., Tinucci-Costa M., Da Silva A.S. (2015). Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma. Pathol. Res. Pract., 211: 677–681.
- Mackay C.R. (2001). Chemokines: immunology's high impact factors. Nat. Immunol., 2: 95–101.
- Maekawa N., Konnai S., Okagawa T., Nishimori A., Ikebuchi R., Izumi Y., Takagi S., Kagawa Y., Nakajima C., Suzuki Y., Kato Y., Murata S., Ohashi K. (2016). Immunohistochemical analysis of PD-L1 expression in canine malignant cancers and PD-1 expression on lymphocytes in canine oral melanoma. PloS one, 11(6): e0157176.
- Maekawa N., Konnai S., Nishimura M., Kagawa Y., Takagi S., Hosoya K., Ohta H., Kim S., Okagawa T., Izumi Y., Deguchi T., Kato Y., Yamamoto S., Yamamoto K., Toda M., Nakajima C., Suzuki Y., Murata S., Ohashi K. (2021). PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma. NPJ Precis. Oncol., 5: 10.
- Maina F., Casagranda F., Audero E., Simeone A., Comoglio P.M., Klein R., Ponzetto C. (1996). Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development. Cell, 87: 531–542.
- Marques O., Canadas A., Faria F., Oliveira E., Amorim I., Seixas F., Gama A., Lobo-da-Cunha A., Silva B.M.D., Porto G., Lopes C. (2017). Expression of iron-related proteins in feline and canine mammary gland reveals unexpected accumulation of iron. Biotech. Histochem., 92: 584–594.
- Michałek K., Seńko P., Bernaciak M., Małkowska P., Dyguś S., Jankowski W., Lepczyński A. (2020). Akwaporyny w gruczole mlekowym oraz ich rola w syntezie mleka (in Polish). PBK, 47: 339–352.
- Moe L. (2001). Population-based incidence of mammary tumours in some dog breeds. J. Reprod. Fertil. Suppl., 57: 439–443.
- Mohan R.R., Tovey J.C.K., Gupta R., Sharma A., Tandon A. (2011). Decorin biology, expression, function and therapy in the cornea. Curr. Mol. Med., 11: 110–128.
- Muñoz M., Rosso M., Coveñas R. (2011). The NK-1 receptor: a new target in cancer therapy. Curr. Drug Targets., 12: 909–921.
- Murphy P.M. (2001). Chemokines and the molecular basis of leukocyte migration. N. Engl. J. Med., 343: 1038–1049.
- Murphy M.P. (2012). Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. Antioxid. Redox Signal., 16: 476–495.
- Nascimento-Hama L.C., Vasconcelos R.deO., De Nardi A.B., Andrade Leite de Camargo A.C., Marchini L.R., Rocha F.D.L., Firmo B.F., Estrada C.R.V., Artoni S.M. B., Nunes N., Panossô A.R., Amoroso L. (2022). Association between vitamin D and malignant mammary tumors in obese female dogs. Braz. J. Vet. Pathol., 15: 20–30.
- Nuzzo P.V., Rubagotti A., Zinoli L., Salvi S., Boccardo S., Boccardo F. (2016). The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome. BMC Cancer, 16: 95.
- Okada S., Furuya M., Fukui-Kaneshige A., Nakanishi H., Tani H., Sasai K. (2021). HSP110 expression in canine mammary gland tumor and its correlation with histopathological classification and grade. Vet. Immunol. Immunopathol., 232: 110171.
- Papazoglou L.G., Basdani E., Rabidi S., Patsikas M.N., Karayiannopoulou M. (2014). Current surgical options for mammary tumor removal in dogs. J. Veter. Sci. Med., 2: 6.
- Pastor N., Caballé N.C., Santella M., Ezquerra L.J., Tarazona R., Duran E. (2018). Epidemiological study of canine mammary tumors: age, breed, size and malignancy. Austral. J. Vet. Sci., 50: 143–147.
- Pimpão C., da Silva I.V., Soveral G. (2025). The expanding role of Aquaporin-1, Aquaporin-3 and Aquaporin-5 as transceptors: involvement in cancer development and potential druggability. Int. J. Mol. Sci., 26: 1330.
- Pineda C., Raya A.I., Morgaz J., Sánchez-Céspedes R., Millán Y., Aguilera-Tejero E., López I. (2024). Vitamin D status in female dogs with mammary gland tumors. J. Vet. Intern. Med., 38: 2257–2264.
- Planellas M., Bassols A., Siracusa C., Saco Y., Giménez M., Pato R., Pastor J. (2009). Evaluation of serum haptoglobin and C-reactive protein in dogs with mammary tumors. Vet. Clin. Pathol., 38: 348–352.
- Pöschel A., Beebe E., Kunz L., Amini P., Guscetti F., Malbon A., Markkanen E. (2021). Identification of disease-promoting stromal components by comparative proteomic and transcriptomic profiling of canine mammary tumors using laser-capture microdissected FFPE tissue. Neoplasia, 23: 400–412.
- Raposo T.P., Beirão B.C.B., Pires I., Prada J., Brilhante P., Argyle D.J., Queiroga F.L. (2016). Immunohistochemical expression of CCR2, CSF1R and MMP9 in canine inflammatory mammary carcinomas. Anticancer Res., 36: 1805–1813.
- Rasotto R., Berlato D., Goldschmidt M.H., Zappulli V. (2017). Prognostic significance of canine mammary tumor histologic subtypes: An observational cohort study of 229 cases. Vet. Pathol., 54: 571–578.
- Ratajczak-Wielgomas K., Dzięgiel P. (2015). The role of periostin in neoplastic processes. Folia Histochem. Cytobiol., 53: 120–132.
- Ren X., Fan Y., Shi D., Liu Y. (2023). Expression and significance of IL-6 and IL-8 in canine mammary gland tumors. Sci. Rep., 13: 1302.
- Riobo-Del Galdo N.A., Lara Montero Á., Wertheimer E.V. (2019). Role of hedgehog signaling in breast cancer: pathogenesis and therapeutics. Cells, 8: 375.
- Rodríguez J., Santana Á., Herráez P., Killick D.R., de Los Monteros A.E. (2022). Epidemiology of canine mammary tumours on the Canary Archipelago in Spain. BMC Vet. Res., 18: 268.
- Romanucci M., Marinelli A., Sarli G., Della Salda L. (2006). Heat shock protein expression in canine malignant mammary tumours. BMC Cancer, 6: 171.
- Salas Y., Márquez A., Diaz D., Romero L. (2015). Epidemiological study of mammary tumors in female dogs diagnosed during the period 2002–2012: A growing animal health problem. PloS One, 10(5): e0127381.
- Salvatore V., Teti G., Focaroli S., Mazzotti M.C., Mazzotti A., Falconi M. (2017) The tumor microenvironment promotes cancer progression and cell migration. Oncotarget, 8: 9608–9616.
- Samadi M., Kamrani A., Nasiri H., Shomali N., Heris J.A., Shahabi P., Ghahremanzadeh K., Mohammadinasab R., Sadeghi M., Sadeghvand S., Shotorbani S.S., Akbari M. (2023). Cancer immunotherapy focusing on the role of interleukins: A comprehensive and updated study. Pathol. Res. Pract., 249: 154732.
- Sánchez-Céspedes R., Fernández-Martínez M.D., Raya A., Pineda C., López I., Millán Y. (2018). Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors. Vet. Comp. Oncol., 16: E185–E193.
- Sánchez-Céspedes R., Fernández-Martínez M.D., Raya A.I., Pineda C., López I., Millán Y. (2021). Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma. BMC Vet. Res., 17: 197.
- Sarhadi V.K., Armengol G. (2022). Molecular bio-markers in cancer. Biomolecules, 12: 1021.
- Schmidt M., Voelker H.U., Kapp M., Krockenberger M., Dietl J., Kammerer U. (2010). Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J. Cancer Res. Clin. Oncol., 136: 219–225.
- Sexauer D., Gray E., Zaenker P. (2022). Tumour-associated autoantibodies as prognostic cancer biomarkers – a review. Autoimmun. Rev., 21: 103041.
- Shosu K., Sakurai M., Inoue K., Nakagawa T., Sakai H., Morimoto M., Okuda M., Noguchi S., Mizuno T. (2016). Programmed cell death ligand 1 expression in canine cancer. In Vivo, 30: 195–204.
- Shrestha L., Bolaender A., Patel H.J., Taldone T. (2016). Heat shock protein (HSP) drug discovery and development: targeting heat shock proteins in disease. Curr. Top. Med. Chem., 16: 2753–2764.
- Song D., Oh Y.I., Kim J.M., Cheon D.S., Kim D.Y., Seo K.W. (2020). Detection of neurokinin-1 receptor by immunohistochemistry in canine mammary gland tumours. Vet. Med. Sci., 6: 958–964.
- Sorenmo K.U., Kristiansen V.M., Cofone M.A., Shofer F.S., Breen A.M., Langeland M., Mongil C.M., Grondahl A.M., Teige J., Goldschmidt M.H. (2009). Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet. Comp. Oncol., 7: 162–172.
- Suvas S. (2017). Role of substance P neuro-peptide in inflammation, wound healing, and tissue homeostasis. J. Immunol., 199: 1543–1552.
- Szczubiał M., Urban-Chmiel R., Łopuszyński W. (2015). Heat shock protein 70 and nitric oxide concentrations in non-tumorous and neoplastic canine mammary tissues: preliminary results – Short communication. Acta Vet. Hung., 63: 209–214.
- Szczubiał M., Krawczyk M., Bochniarz M., Dąbrowski R., Łopuszyński W., Urban-Chmiel R. (2018). Comparison of plasma interleukin-6 and interleukin-10 concentrations between female dogs with mammary gland tumours and healthy. Pak. Vet. J., 38: 194–198.
- Szczubiał M., Kankofer M., Wawrzykowski J., Dąbrowski R., Łopuszyński W., Bochniarz M., Brodzki P. (2020). Decorin concentrations in canine normal and neoplastic mammary gland tissues. Reprod. Domest. Anim., 55: 1404–1410.
- Szczubiał M., Łopuszyński W., Dąbrowski R., Bochniarz M., Brodzki P. (2022). Plasma interleukin-1α and interleukin-8 in female dogs with non-metastatic and metastatic malignant mammary gland tumours. Pol. J. Vet. Sci., 25: 317–324.
- Szczubiał M., Łopuszyński W., Dąbrowski R., Jamioł M., Bochniarz M., Brodzki P. (2023). Plasma levels of chemokines CCL2 and CXCL12 in female dogs with malignant mammary gland tumours without and with metastases. Pol. J. Vet. Sci., 26: 385–392.
- Tao L., Qiu J., Slavin S., Ou Z., Liu Z., Ge J., Zuo L., Guancial E.A., Messing E.M., Chang C., Yeh S. (2018). Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals. Cancer Lett., 430: 215–223.
- Tecles F., Caldín M., Zanella A., Membiela F., Tvarijonaviciute A., Subiela S.M., Cerón J.J. (2009). Serum acute phase protein concentrations in female dogs with mammary tumors. J. Vet. Diagn. Invest., 21: 214–219.
- Topalian S.L., Drake C.G., Pardoll D.M. (2015). Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell, 27: 450–461.
- Trusolino L., Bertotti A., Comoglio P.M. (2010). MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol., 11: 834–848.
- Vascellari M., Capello K., Carminato A., Zanardello C., Baioni E., Mutinelli F. (2016). Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer. Prev. Vet. Med., 126: 183–189.
- Vazquez E., Lipovka Y., Cervantes-Arias A., Garibay-Escobar A., Haby M.M., Queiroga F.L., Velazquez C. (2023). Canine mammary cancer: State of the art and future perspectives. Animals, 13: 3147.
- Vu T.T., Marquez J., Le L.T., Nguyen A.T.T., Kim H.K., Han J. (2018). The role of decorin in cardiovascular diseases: more than just a decoration. Free Radic. Res., 52: 1210–1219.
- Whitley D., Goldberg S.P., Jordan W.D. (1999). Heat shock proteins: a review of the molecular chaperones. J. Vasc. Surg., 29: 748–751.
- Wu C.C., Chang S.C., Zeng G.Y., Chu H.W., Huang Y., Liu H.P. (2019). Proteome analyses reveal positive association of COL2A1, MPO, TYMS, and IGFBP5 with canine mammary gland malignancy. Proteomics Clin. Appl., 13: e1800151.
- Xu I.M., Lai R.K., Lin S.H., Tse A.P., Chiu D.K., Koh H.Y., Law C.T., Wong C.M., Cai Z., Wong C.C., Ng I.O. (2016). Transketolase counteracts oxidative stress to drive cancer development. Proc. Natl. Acad. Sci. USA, 113: E725–34.
- Yang W.Y., Liu C.H., Chang C.J., Lee C.C., Chang K.J., Lin C.T. (2006). Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours. J. Comp. Pathol., 134: 70–79.
- Yuan S.H., Chang S.C., Chou P.Y., Yang Y., Liu H.P. (2022). The implication of serum auto-antibodies in prognosis of canine mammary tumors. Animals, 12: 2463.
- Yue B. (2014). Biology of the extracellular matrix: an overview. J. Glaucoma, 23 (8 Suppl 1): S20–S23.
- Zhang W., Ge Y., Cheng Q., Zhang Q., Fang L., Zheng J. (2018). Decorin is a pivotal effector in the extracellular matrix and tumour micro-environment. Oncotarget, 9: 5480–5491.
- Zhang Y., Liu Y., Liu H., Tang W.H. (2019). Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci., 9: 1–18.
- Zheng H.H., Du C.T., Yu C., Zhang Y.Z., Huang R.L., Tang X.Y., Xie G.H. (2022). Epidemiological investigation of canine mammary tumors in mainland China between 2017 and 2021. Front. Vet. Sci., 9: 843390.
DOI: https://doi.org/10.2478/aoas-2026-0017 | Journal eISSN: 2300-8733 (formerly 1642-3402) | Journal ISSN: 1642-3402
Language: English
Submitted on: Jun 3, 2025
Accepted on: Feb 24, 2026
Published on: Oct 5, 2026
Published by: National Research Institute of Animal Production
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Mateusz Bernaciak, Mariusz Pierzchała, Brygida Ślaska, Adam Lepczyński, published by National Research Institute of Animal Production
This work is licensed under the Creative Commons Attribution 3.0 License.